Pamela F Weiss

Dados Biográficos

ID8258684
NOMEPamela F Weiss
PRENOMESPamela F
SOBRENOMEWeiss
ASSINATURAWEISS P F
AFILIAÇÕESChildren's Hospital of Philadelphia
ORCID0000-0002-9724-0443
VERIFICADOSim
TOTAL DE OBRAS5
TOTAL DE CITAÇÕES0
TOTAL COMO AUTOR5
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2022
ANO MAIS RECENTE DE PUBLICAÇÃO2026
ÍNDICE H0

  • Examining Hope in Adolescents with Chronic Musculoskeletal Pain

    Open AccessIrene Chern, Nellie Butler et al.ARTICLEChildren2026

    Background/Objectives: This cross-sectional study aimed to quantify hope levels in adolescents with chronic musculoskeletal pain (CMP) and examine patient-reported outcomes associated with hope. Methods: This was an exploratory, cross-sectional, secondary analysis of baseline data from a prospective, single-center longitudinal study of 60 youth presenting for an initial evaluation at a pediatric subspecialty pain clinic. Subjects were English-spe…

  • A Pilot Study on the Freelisting Method Among Adolescents with Chronic Musculoskeletal Pain

    Open AccessSabrina Gmuca, Dori Abel et al.ARTICLEChildren2024

    Background/Objectives : To assess the feasibility and acceptability of freelisting for adolescents with chronic musculoskeletal pain (CMP) and use freelisting to identify how adolescents with CMP cope with pain. Methods : This was a mixed-methods cross-sectional single-center study of patients 12-18 years old, diagnosed with CMP. Twenty-seven subjects participated in an interview which included the freelisting exercise, probing questions, Connor-…

  • Stakeholder outcome prioritization in the Biologic Abatement and Capturing Kids' Outcomes and Flare Frequency in Juvenile Spondyloarthritis (Back‐OFF JSpA) trial

    Open AccessEmily Neu, Cora Sears et al.ARTICLEHealth Expectations2023

    BACKGROUND: The Biologic Abatement and Capturing Kids' Outcomes and Flare Frequency in Juvenile Spondyloarthritis (BACK-OFF JSpA) study is a randomized, pragmatic trial investigating different tumour necrosis factor inhibitor de-escalation strategies for children with sustained inactive disease. In this project, we elicited concept rankings that aided in the selection of the patient-reported outcome (PRO) measures that should be examined as part …

  • The Feasibility and Acceptability of Resilience Coaching for Adolescent Chronic Musculoskeletal Pain

    Open AccessSabrina Gmuca, Pamela F Weiss et al.ARTICLEChildren2022

    Promoting Resilience in Stress Management (PRISM) is a well-established resilience coaching program for youth with chronic illness. It is a one-on-one intervention targeting skills in stress management, goal-setting, cognitive reframing, and meaning-making. We aimed to (i) assess the feasibility and acceptability of PRISM and (ii) explore PRISM's impact on clinical outcomes among youth with chronic musculoskeletal pain (CMP). This was a single-ar…

  • Impact of HLA-B27 and Disease Status on the Gut Microbiome of the Offspring of Ankylosing Spondylitis Patients

    Open AccessMatthew L Stoll, Kimberly DeQuattro et al.ARTICLEChildren2022

    Multiple studies have shown the microbiota to be abnormal in patients with spondyloarthritis (SpA). The purpose of this study was to explore the genetic contributions of these microbiota abnormalities. We analyzed the impact of HLA-B27 on the microbiota of children at risk for SpA and compared the microbiota of HLA-B27+ pediatric offspring of ankylosing spondylitis (AS) patients with that of HLA-B27+ children with SpA. Human DNA was obtained from…